Speaking to news agency The Associated Press, health director Dr. Mustafa Bitte confirmed a wave of children’s deaths from severe kidney injury, shocking 2.4 million people across the country and around the world.
The Indian government today launched an investigation into the manufacture of four cough syrups by a Haryana-based pharmaceutical company, following an alert issued by the World Health Organization (WHO).
News agency PTI quoted a source as saying, “While all necessary steps will be taken, as a strong regulatory authority, the WHO will share the report at the earliest on establishing a causal relationship with the CDSCO (Central Drugs Standard Control Organisation). For deaths with the medical products in question, labels/photos of the products etc.”
The WHO said the syrup could be linked to the deaths of 66 children in The Gambia. It states that the manufacturer has not given any guarantee to WHO on the safety and quality of these products.
“Laboratory analysis of samples of each of the four products confirms that they contain unacceptable amounts of diethylene glycol and ethylene glycol as contaminants. To date, four of these products have been identified in The Gambia, but may have been distributed through informal markets to other countries or regions,” WHO said.
The four products are Promethazine Oral Solution, Cofexamalin Baby Cough Syrup, Macoff Baby Cough Syrup and Magrip N Cold Syrup.